Author:
Cavalli Zoé,Becker Agathe,Bosch Alexie,Conrad Anne,Triffault-Filit Claire,Valour Florent,Laurent Frederic,Cohen Sabine,Chidiac Christian,Ferry Tristan
Abstract
Abstract. We reviewed all outpatients with bone and joint infection treated with cefoxitin in continuous intravenous infusion using mobile elastomeric infusors in our regional reference center between 2014 and 2017. The stability of cefoxitin provides an interesting and well-tolerated alternative for continuous infusion in outpatients with polymicrobial bone and joint infection.
Subject
Infectious Diseases,Orthopedics and Sports Medicine,Surgery
Reference16 articles.
1. American Society of Health-System Pharmacists. Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery. 2013. Available from: https:// www.ashp.org/-/media/assets/policy-guidelines/docs/therapeutic-guidelines/therapeutic-guidelines-antimicrobial-prophylaxis-surgery.ashx?la=en&hash=A15B4714417A51A03E5BDCAC150B94EAF899D49B.
2. Schurman DJ, Dillingham M. Clinical evaluation of cefoxitin in treatment of infections in 47 orthopedic patients. Rev Infect Dis. 1979 Feb;1(1):206–9.
3. Webb D, Thadepalli H, Bach V, Roy I. Clinical and experimental evaluation of cefoxitin therapy. Chemotherapy. 1979;25(4):233–42.
4. Perkins RL, Slama TG, Fass RJ, Prior RB, Plouffe JF, Warner JF. et al. Therapy of skin, soft tissue, and bone infections with cefoxitin sodium. Rev Infect Dis. 1979 Feb;1(1):165–9.
5. Cefoxitin - FDA prescribing information, side effects and uses. Drugs.com. Available from: https:// www.drugs.com/pro/cefoxitin.html.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献